ArticleJAMA network open2025
Population-Level Health Intervention and Primary Care Quality for Veterans.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Integrated Care to Learning Systems.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: The COVID-19 pandemic caused substantial disruptions to primary care, potentially impacting quality of care for chronic conditions. The Veterans Health Administration (VHA) implemented the Preventive Health Inventory (PHI) initiative, a multicomponent care management intervention, focused on chronic disease care and preventive screening to support the delivery of delayed care. Objective: To examine the association of PHI implementation with measures of primary care quality and potentially avoidable health care use. Design, Setting, and Participants: This cohort study used VHA administrative data of multiple propensity score-matched cohorts of veterans with diabetes and/or hypertension enrolled in primary care who received or did not receive care via the PHI. Data were collected from February 1, 2021, through February 28, 2022, and analyzed between April 30 and June 28, 2024. Exposure: Templated electronic health record note documenting use of the PHI. Main Outcomes and Measures: A difference-in-differences approach was used to evaluate the association of PHI receipt with diabetes and hypertension clinical quality measures (eg, poor diabetes control with a hemoglobin A1c >9% [75 mmol/mol]) and preventable use outcomes, including outpatient care use, preventable emergency department visits, and hospitalizations for ambulatory care-sensitive conditions. Results: For each outcome, separate cohorts of veterans who received the PHI intervention (from 8434 [statin therapy] to 97 695 [preventable care use outcomes]) were propensity score matched with those who did not (from 5574 [statin therapy] to 118 188 [preventable care use outcomes]). Veterans who received care using the PHI tool had a lower probability of poor diabetes control (2.9 percentage points [95% CI, -3.8 to -1.9 percentage points]) and a higher probability of adequate blood pressure control (4.0 percentage points [95% CI, 2.6-5.3 percentage points]). No differences were observed between groups for statin therapy or preventable use outcomes. Use of the PHI was associated with increased outpatient care use (310 [95% CI, 272-348] visits per 1000 veterans). Conclusions and Relevance: This cohort study found that implementation of VHA's PHI was associated with improved care quality of care for diabetes and hypertension and did not increase preventable care use, suggesting that the PHI may serve as a model for population health approaches that seek to reengage inactive patients since the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.